Artificial Intelligence Revolutionizing the Pharmaceutical Industry, 2018 Research Study - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Artificial
Intelligence Revolutionizing the Pharmaceutical Industry”

report has been added to ResearchAndMarkets.com’s
offering.

The impressive advances in life sciences research and development (R&D)
befallen in the past two/three years are playing a leading role in the
transformation of the healthcare industry.

A myriad of new developments in the fields of gene and cell therapies,
empowered with nanotechnology advances, omics technologies and novel
smart molecules approaches are extensively enlightening drug discovery
and the development landscape for the effective treatment of diseases.
AI is pursued to provide the best suited approach to leverage scientific
literature, patients’ omics-data and overall clinical data to drive
smart decisions.

Key Topics Covered:

1. Executive Summary

2. Technology Snapshot And Trend

3. Technology Status Review And Assessment

4. Artificial Intelligence Business Landscape

5. Artificial Intelligence Benchmarking Model

6. Artificial Intelligence Innovation Scorecard

7. Funding And Investment

8. Technology Trends And Roadmapping

9. Key Industry Influencers

10. Appendix

Companies Mentioned

  • AcuraStem
  • BenevolentAI
  • Berg
  • Evid Science
  • FDNA
  • Inoplexus
  • Kyndi
  • ReviveMed
  • Standigm
  • Structura Bio

For more information about this report visit https://www.researchandmarkets.com/research/srhxmj/artificial?w=4

(Excerpt) Read more Here | 2018-12-04 18:37:00
Image credit: source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.